Lazcluze 240 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F66H7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,009
Award facts
- Contract value 100% obligated
- $13,008.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,008.51 to AmerisourceBergen Drug Corp for the supply of Lazcluze 240 mg tablets (30-count units) on January 21, 2026, with completion scheduled for February 11, 2026. The contract utilizes a firm fixed-price structure and carries no set-aside designation, indicating full and open competition. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The contractor's existing federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F66H7?
SPE2DR26F66H7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F66H7 worth?
The government has obligated $13,009 on SPE2DR26F66H7.
Is contract SPE2DR26F66H7 an order under another contract?
Yes. SPE2DR26F66H7 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66H7 competed?
The extent of competition for SPE2DR26F66H7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award